Menstruation and Migraine: Can We End the Cycle?
Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.
TYPE 2 DIABETES ADVISOR
Type 2 Diabetes Advisor
Feature
-
-
Point: Dietary Supplements Can Mitigate Poor Diet, Improve Health
Although it is estimated that more than 166 million Americans use dietary supplements, many healthcare providers are unfamiliar with how these substances are regulated by the US Food and Drug Administration. -
Counterpoint: Dietary Supplements Are Largely Unnecessary
In Part 2 of this feature pair, Erin D. Michos, MD, shares her thoughts on why dietary supplements are largely unnecessary. -
In the Spotlight: How Racism Affects the Healthcare Workforce
Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce? -
Cushing Syndrome in Pregnancy: When to Suspect and How to Treat
Despite the preponderance of CS in women of childbearing age and the likelihood of pregnancy triggering CS, the condition is often overlooked because of the overlap of pregnancy and hypercortisolism symptoms. -
Improving Care for T2D in Patients With Severe Mental Illness: Expert Q&A
Despite the clear need for improved management of T2D in patients with SMI, there is scant evidence regarding effective treatment strategies for this group. -
Managing Bisphosphonate Drug Holidays in Patients With Osteoporosis
Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug. -
Common Interferences in Thyroid Immunoassays
Despite the benefits of using immunoassays in clinical laboratories, various types of interference can lead to inaccurate results that cloud clinical decision-making.
LATEST CONTENT
Modifiable Risk Factors Associated With Prediabetes and T2D Following a Coronary Event
Investigators sought to identify sociodemographic, medical, and psychosocial factors associated with prediabetes and type 2 diabetes.
Predictive Capabilities of Urine Metabolites on Progressive Chronic Kidney Disease in T2D
Investigators examine whether urine metabolites in the tricarboxylic acid cycle can independently predict the risk for CKD progression in individuals with type 2 diabetes.
Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
The use of liraglutide in patients with type 2 diabetes did not increase the risk for diabetes-related foot ulcers.
Bariatric Surgery Reduces Microvascular Disease in Type 2 Diabetes
Investigators sought to determine whether bariatric surgery was associated with lower incidence of microvascular disease for patients with T2D and severe obesity.
Inflammation and Endothelial Stress Associated With CV Risk in Type 2 Diabetes With Manifest CVD
The risk for cardiovascular events in patients with type 2 diabetes without manifest cardiovascular disease is primarily related to the severity of atherosclerosis.
Journal Articles
Stähli BE, Nozza A, Schrieks IC, et al. Homeostasis model assessment of insulin resistance and survival in patients with diabetes and acute coronary syndrome.
J Clin Endocrinol Metab. 2018 ;103(7):2522-2533.
J Clin Endocrinol Metab. 2018 ;103(7):2522-2533.
van Stee MF, de Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
Cardiovasc Diabetol. 2018; ;17(1):94.
Cardiovasc Diabetol. 2018; ;17(1):94.
Guja C, Frías JP, Somogyi A, et al. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
Diabetes Obes Metab. 2018; 20(7):1602-1614.
Diabetes Obes Metab. 2018; 20(7):1602-1614.
Bullard KM, Cowie CC, Lessem SE, et al. Prevalance of diagnosed diabetes in adults by diabetes type – United States, 2016.
MMWR Morb Mortal Wkly Rep. 2018;67(12):359-361.
MMWR Morb Mortal Wkly Rep. 2018;67(12):359-361.
Heinzel A, Kammer M, Mayer G, et al. Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes
[published online July 6, 2018]. Diabetes Care. doi: 10.2337/dc18-0532
[published online July 6, 2018]. Diabetes Care. doi: 10.2337/dc18-0532
Perkovic V, Zeeuw D, Mahaffey KW et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
[published online June 21, 2018]. Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(18)30141-4
[published online June 21, 2018]. Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(18)30141-4
Patient Education Materials
Related Links (set in alphabetical order):
- National Institute of Diabetes and Digestive and Kidney Diseases: Diabetes Discoveries & Practice Blog
- National Institute of Diabetes and Digestive and Kidney Diseases: Game Plan for Preventing Type II Diabetes
- National Institute of Diabetes and Digestive and Kidney Diseases: Practice Transformation for Physicians and Health Care Teams
- National Institute of Diabetes and Digestive and Kidney Diseases: Guiding Principles for Diabetes Care
- American Diabetes Association: Type 2 Diabetes
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes Advisor
